TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9917447

Group type: EXPERIMENTAL
Intervention: Audiotaped STD risk assessment and education about staying safe (safer = condoms, safest = abstinence)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 215
Study: 7478826

Group type: EXPERIMENTAL
Intervention: LC-PUFA-supplemented formula
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard infant formula
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Breast-fed exclusively
Number of subjects: 90
Study: 1832359

Group type: EXPERIMENTAL
Intervention: HbA1
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Fructosamine
Number of subjects: 1030
Study: 6308996

Group type: EXPERIMENTAL
Intervention: Locust bean gum (LBG) food products (8 to 30 g/day)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control feeding periods (without LBG)
Number of subjects: 38
Study: 30454724

Group type: EXPERIMENTAL
Intervention: Surgically closed VSD
Number of subjects: 96

Group type: COMPARATOR
Intervention: Unrepaired VSD
Number of subjects: 96

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 96
Study: 30615489

Group type: EXPERIMENTAL
Intervention: Cooling vest during exercise
Number of subjects: 10

Group type: COMPARATOR
Intervention: No cooling vest during exercise
Number of subjects: 10
Study: 26562708

Group type: EXPERIMENTAL
Intervention: Creatine (20 g)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (20 g corn starch maltodextrin)
Number of subjects: 9
Study: 24490871

Group type: EXPERIMENTAL
Intervention: StepUp program (6-week pedometer-based self-management program)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study: 21733988

Group type: EXPERIMENTAL
Intervention: Yoga program (twice a week for 8 weeks)
Number of subjects: 90
Study: 19691996

Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (PP group)
Number of subjects: 763

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 763
Study: 17089153

Group type: COMPARATOR
Intervention: Exercise training (ET; n = 7, 40 min session(‐1), five times per week at 60% VO2max)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Carnitine supplementation (CS; n = 7, 4 g day(‐1))
Number of subjects: 28

Group type: COMPARATOR
Intervention: Exercise training and carnitine supplementation (CT; n = 7)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (CON; n = 7)
Number of subjects: 28
Study: 15868619

Group type: EXPERIMENTAL
Intervention: Computerized nailfold video capillaroscopy system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (healthy subjects + primary RP patients)
Number of subjects: 120
Study: 12215207

Group type: EXPERIMENTAL
Intervention: L-carnitine plus zidovudine (AZT) and didanosine (DDI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: zidovudine (AZT) and didanosine (DDI) without L-carnitine
Number of subjects: 20
Study: 10786501

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (5 sessions, 12.4 minutes each)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Simple presence (5 sessions, 10.3 minutes each)
Number of subjects: 27
Study: 7876438

Group type: EXPERIMENTAL
Intervention: Notched-noise maskers (NN) and narrow-band maskers (NB) in a background of spectrally shaped broadband noise (SSBB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consonant recognition in SSBB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined-masker conditions using a modified power-law model of masking additivity
Number of subjects: 0
Study: 1972375

Group type: EXPERIMENTAL
Intervention: Parenteral infusion programs with varying carbohydrate and lipid content (up to 40% of total caloric content)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lipid solutions used as an energy source in early postoperative period
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Laboratory parameters including nitrogen balance, acute phase proteins, and liver function tests
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Transient rise of bilirubin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rise in acute phase proteins
Number of subjects: 32
Study: 6992938

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulphadiazine (T-S)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 31971915

Group type: EXPERIMENTAL
Intervention: Educational workshop
Number of subjects: 64

Group type: COMPARATOR
Intervention: Educational package
Number of subjects: 64
Study: 31050952

Group type: EXPERIMENTAL
Intervention: PBM‐T alone (n = 17), low‐intensity laser (LIL) irradiation (wavelength 660 nm, continuous mode, spot energy 4 J, energy density 142 J/cm2, irradiation time 40 s per spot), once weekly for 4 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: PBM‐T+PDT (n = 14), combination of PBM‐T and PDT with curcumin as photosensitizer, curcumin solution rinse for 5 min, blue light‐emitting diode irradiation for 5 min, LIL applied as in PBM‐T group
Number of subjects: 31
Study: 27516235

Group type: EXPERIMENTAL
Intervention: Strict BP control (mean arterial pressure ≤92 mmHg)
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Usual BP control (mean arterial pressure 102-107 mmHg)
Number of subjects: 1067
Study: 27480383

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isotonic saline injection (control)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups during saline-induced pain
Number of subjects: 26
Study: 24370194

Group type: EXPERIMENTAL
Intervention: Dietary intervention (higher fibre intake)
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Toothbrushing frequency
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1062
Study: 23335901

Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day, N=32)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (N=35)
Number of subjects: 67
Study: 20027357

Group type: EXPERIMENTAL
Intervention: Afala in complex treatment
Number of subjects: 0
Study: 17536986

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 28

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 28
Study: 15117299

Group type: EXPERIMENTAL
Intervention: Direct observation of treatment by community health workers (CHWs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct observation of treatment by family members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community-based DOTS implementation
Number of subjects: 0
Study: 11805568

Group type: EXPERIMENTAL
Intervention: Colonic transit study (first and second tests)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with colonic inertia
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with paradoxical puborectalis contraction
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Colonic transit study for patients with chronic idiopathic constipation
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Repeat transit study confirming inertia before colectomy
Number of subjects: 51
Study: 9669221

Group type: EXPERIMENTAL
Intervention: Phlebography
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Duplex ultrasonography
Number of subjects: 24
Study: 8149522

Group type: EXPERIMENTAL
Intervention: Hirulog (direct thrombin inhibitor)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Heparin (control)
Number of subjects: 45
Study: 2970776

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t‐PA) 150 mg over 8 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous tissue plasminogen activator (t‐PA)
Number of subjects: 40
Study: 29659751

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 575

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 575
Study: 28215615

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate therapy for 5 years (240 weeks)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Baseline steatosis score of 5% or greater (grade 1 or more)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Steatosis score at year 5
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: HBeAg seropositivity at baseline
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Age 40 years or older
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: HBeAg-positive patients with steatosis at baseline
Number of subjects: 471
Study: 26305876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 23926586

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allografts (ADM group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Free gingival grafts (FGG group)
Number of subjects: 36
Study: 21068351

Group type: EXPERIMENTAL
Intervention: High-cocoa flavanol (HCF) group (494 mg cocoa flavanols/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low-cocoa flavanol (LCF) group (23 mg cocoa flavanols/d)
Number of subjects: 22
Study: 18948128

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with no GMP
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with naturally present 21% GMP
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) with naturally present 21% GMP plus added GMP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Maltodextrin carbohydrate (control)
Number of subjects: 50
Study: 17259090

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 573L/1‐3 strains
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus 573L/1 strain
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strains
Number of subjects: 46
Study: 14737725

Group type: EXPERIMENTAL
Intervention: TRAK Assay
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: TRAK Dyno human
Number of subjects: 467
Study: 10873356

Group type: EXPERIMENTAL
Intervention: Augmentin 1.2 g (intravenous antibiotic prophylaxis)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 334
Study: 9093048

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tilt up guided treatment
Number of subjects: 20
Study: 1487340

Group type: EXPERIMENTAL
Intervention: Low intensity training (LO; n = 8)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High intensity training (HI; n = 11)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CON; n = 5)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24
Study: 3942545

Group type: EXPERIMENTAL
Intervention: Random Dot E (RDE) stereogram
Number of subjects: 483

Group type: COMPARATOR
Intervention: Modified Clinical Technique (MCT)
Number of subjects: 483
Study: 29145076

Group type: EXPERIMENTAL
Intervention: Integrative Exercise (IE)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waitlist Control (WL)
Number of subjects: 47
Study: 26321469

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined Antioxidant Therapy (CAT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25168637

Group type: EXPERIMENTAL
Intervention: High-sensitivity C-reactive protein (hsCRP)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Matrix metalloproteinase (MMP)-mediated breakdown of CRP (CRPM)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Pressure-pain thresholds (PPT)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Temporal summation of pain
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Conditioning pain modulation (CPM)
Number of subjects: 281
Study: 22664945

Group type: EXPERIMENTAL
Intervention: Neurotropin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no neurotropin)
Number of subjects: 80
Study: 21029014

Group type: EXPERIMENTAL
Intervention: Masked Hypertension (MH)
Number of subjects: 1019

Group type: COMPARATOR
Intervention: White-Coat Hypertension (WCH)
Number of subjects: 1019
Study: 18410212

Group type: EXPERIMENTAL
Intervention: Family Foundations intervention (8 classes before and after birth)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 169
Study: 16078954

Group type: EXPERIMENTAL
Intervention: Extensive intervention group (EIG) - individualized interventions comprising exercise and strategies for maximizing vision and sensation
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Extensive exercise intervention group (part of EIG)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Extensive visual intervention group (part of EIG)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Minimal intervention group (MIG) - received brief advice
Number of subjects: 620

Group type: COMPARATOR
Intervention: Control group (CG) - received no intervention
Number of subjects: 620
Study: 12613401

Group type: EXPERIMENTAL
Intervention: Lactovegetarian diet with 10 en% ghee for 8 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mustard oil diet (control)
Number of subjects: 24
Study: 10619581

Group type: EXPERIMENTAL
Intervention: 5 mg ramipril daily for 6 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 8533913

Group type: EXPERIMENTAL
Intervention: Desflurane at 0.5 MAC (3.5%)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Desflurane at 0.8 MAC (5.6%)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 9
Study: 2035795

Group type: EXPERIMENTAL
Intervention: Midazolam and droperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Papaveretum and hyoscine
Number of subjects: 0
Study: 7243896

Group type: EXPERIMENTAL
Intervention: Applied kinesiology technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo technique
Number of subjects: 20
Study: 31125701

Group type: EXPERIMENTAL
Intervention: High‐intensity interval training (HIIT - 10 × 1:1 min 100% VO2max; n = 13)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moderate‐intensity continuous training (MICT - ˜35 min 65% VO2max; n = 13)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no training; n = 6)
Number of subjects: 32
Study: 27814933

Group type: EXPERIMENTAL
Intervention: Shock wave + wrist splint
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wrist splint
Number of subjects: 40
Study: 25546556

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 23764516

Group type: EXPERIMENTAL
Intervention: High-dose, high-repetition medical exercise therapy (MET)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Low-dose, low-repetition exercise therapy (Control)
Number of subjects: 28
Study: 20613653

Group type: EXPERIMENTAL
Intervention: Weight training session
Number of subjects: 30
Study: 19523680

Group type: EXPERIMENTAL
Intervention: Daily vaginal progesterone gel 90 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Progesterone (meta-analysis)
Number of subjects: 500
Study: 17095018

Group type: EXPERIMENTAL
Intervention: Arundic acid (AA) at 8 mg/kg/h
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 15345913

Group type: EXPERIMENTAL
Intervention: Levocetirizine (LCZ)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Desloratadine (DL)
Number of subjects: 23
Study: 11516602

Group type: EXPERIMENTAL
Intervention: COMFORT 'behavior' scale
Number of subjects: 204

Group type: COMPARATOR
Intervention: Neonates
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Pain characteristics
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Physical condition
Number of subjects: 204
Study: 9696963

Group type: EXPERIMENTAL
Intervention: Dimethicone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (without dimethicone)
Number of subjects: 12
Study: 7654156

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Group Therapy (CBGT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure‐based treatment without formal cognitive restructuring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 2516883

Group type: EXPERIMENTAL
Intervention: Triamterene (100 mg orally)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1105267

Group type: EXPERIMENTAL
Intervention: Clonidine at a daily dose of 150 mug
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31003735

Group type: EXPERIMENTAL
Intervention: Once-daily prolonged-release tacrolimus (PRT)
Number of subjects: 24
Study: 26094993

Group type: EXPERIMENTAL
Intervention: Zonisamide 50 mg/d
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg/d
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study: 23165200

Group type: EXPERIMENTAL
Intervention: High working memory capacity (WMC) individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low working memory capacity (WMC) individuals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predominantly incongruent blocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predominantly congruent blocks
Number of subjects: 0
Study: 21663812

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.025 μg/kg/min (Group R25)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.05 μg/kg/min (Group R50)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.075 μg/kg/min (Group R75)
Number of subjects: 44
Study: 18835692

Group type: EXPERIMENTAL
Intervention: Cobalt-chrome femoral stems
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Titanium femoral stems
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Cementless, flat, tapered wedge femoral stem design
Number of subjects: 390
Study: 16398750

Group type: EXPERIMENTAL
Intervention: Stepping Stones intervention (50 hours over 17 sessions in 35 communities)
Number of subjects: 2776

Group type: COMPARATOR
Intervention: Control group (single session of about 3 hours on HIV and safer sex)
Number of subjects: 2776

Group type: EXPERIMENTAL
Intervention: Stepping Stones intervention
Number of subjects: 2776

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2776
Study: 15572499

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (preincision)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (postsurgical)
Number of subjects: 0
Study: 11442498

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 4012
Study: 9346997

Group type: EXPERIMENTAL
Intervention: Homemade CBORS
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Packet CBORS
Number of subjects: 232

Group type: COMPARATOR
Intervention: Pedialyte
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 232
Study: 7658999

Group type: EXPERIMENTAL
Intervention: Clonidine test (100 micrograms/m2 surface)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exercise-Propranolol test (0.5 mg/kg weight)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of B vs B and Max Resp vs Max Resp in both groups
Number of subjects: 40
Study: 3098950

Group type: EXPERIMENTAL
Intervention: High calcium and phosphorus content parenteral nutrition (60-80 mg Ca and 46.5-62 mg P/dl)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low calcium and phosphorus content parenteral nutrition (20 mg Ca and 15.5 mg P/dl)
Number of subjects: 18
Study: 30345850

Group type: EXPERIMENTAL
Intervention: Self-regulatory biofeedback intervention program (HRVCB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High intensity interval training protocol (HIIT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All participants (HRVCB, HIIT, and waitlist)
Number of subjects: 90
Study: 27745535

Group type: EXPERIMENTAL
Intervention: Telephone care management (TCM)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Usual outpatient mental health treatment
Number of subjects: 358
Study: 25901477

Group type: EXPERIMENTAL
Intervention: Opioid + pain (intravenous fentanyl 1 μg/kg and cold-pressor pain)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Opioid only (intravenous fentanyl 1 μg/kg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Pain only (cold-pressor)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 21
Study: 24050764

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Lenograstim
Number of subjects: 29
Study: 21527296

Group type: EXPERIMENTAL
Intervention: T73T mutation group
Number of subjects: 7

Group type: COMPARATOR
Intervention: P73P mutation group
Number of subjects: 7
Study: 18083065

Group type: EXPERIMENTAL
Intervention: Letrozole for 5 years
Number of subjects: 4922

Group type: COMPARATOR
Intervention: Tamoxifen for 5 years
Number of subjects: 4922
Study: 16515924

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 157

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 157
Study: 14753482

Group type: EXPERIMENTAL
Intervention: Early Surgical Intervention
Number of subjects: 985

Group type: COMPARATOR
Intervention: Initial Conservative Treatment
Number of subjects: 985
Study: 10879362

Group type: EXPERIMENTAL
Intervention: Distraction using a kaleidoscope
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control group (no distraction)
Number of subjects: 384
Study: 8856385

Group type: EXPERIMENTAL
Intervention: Distant cooling
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Inspiratory gasp test
Number of subjects: 63
Study: 2045530

Group type: EXPERIMENTAL
Intervention: Captopril (0.7 mg/kg for young, 1.2 mg/kg for elderly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6861601

Group type: EXPERIMENTAL
Intervention: Phenobarbital 5 mg/kg/day for 5 to 12 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation in both groups
Number of subjects: 74